These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32112223)

  • 21. Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China.
    Chen X; Guo X; He P; Nie J; Yan X; Zhu J; Zhang L; Mao G; Wu H; Liu Z; Aga D; Xu P; Smith M; Ren X
    Toxicol Sci; 2017 Jan; 155(1):124-134. PubMed ID: 27637898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean women.
    Harari F; Engström K; Concha G; Colque G; Vahter M; Broberg K
    Environ Health Perspect; 2013 Jul; 121(7):797-803. PubMed ID: 23665909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility.
    Antonelli R; Shao K; Thomas DJ; Sams R; Cowden J
    Environ Res; 2014 Jul; 132():156-67. PubMed ID: 24792412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.
    de la Rosa R; Steinmaus C; Akers NK; Conde L; Ferreccio C; Kalman D; Zhang KR; Skibola CF; Smith AH; Zhang L; Smith MT
    Environ Mol Mutagen; 2017 Jul; 58(6):411-422. PubMed ID: 28640505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Gao C; Lin L; Li J; Wu M; Lv J; Tian S; Hai X
    Toxicol Lett; 2023 May; 380():31-39. PubMed ID: 37024065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan.
    Hsieh RL; Su CT; Shiue HS; Chen WJ; Huang SR; Lin YC; Lin MI; Mu SC; Chen RJ; Hsueh YM
    Toxicol Appl Pharmacol; 2017 Apr; 321():37-47. PubMed ID: 28235556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysis.
    Drobná Z; Martin E; Kim KS; Smeester L; Bommarito P; Rubio-Andrade M; García-Vargas GG; Stýblo M; Zou F; Fry RC
    Reprod Toxicol; 2016 Jun; 61():28-38. PubMed ID: 26928318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of arsenic (+3 oxidation state) methyltransferase in arsenic mediated APL treatment: an in vitro investigation.
    Maimaitiyiming Y; Wang C; Xu S; Islam K; Chen YJ; Yang C; Wang QQ; Naranmandura H
    Metallomics; 2018 Jun; 10(6):828-837. PubMed ID: 29774349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic metabolites; selenium; and AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A polymorphisms in Croatian-Slovenian population from PHIME-CROME study.
    Stajnko A; Šlejkovec Z; Mazej D; France-Štiglic A; Briški AS; Prpić I; Špirić Z; Horvat M; Falnoga I
    Environ Res; 2019 Mar; 170():301-319. PubMed ID: 30612060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam.
    Agusa T; Iwata H; Fujihara J; Kunito T; Takeshita H; Minh TB; Trang PT; Viet PH; Tanabe S
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):131-41. PubMed ID: 19371612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients.
    Lv J; Wu M; Pang C; Duan R; Zhang H; Tian S; Yang H; Hai X
    Biomed Pharmacother; 2023 Jul; 163():114858. PubMed ID: 37172335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms.
    Agusa T; Fujihara J; Takeshita H; Iwata H
    Int J Mol Sci; 2011; 12(4):2351-82. PubMed ID: 21731446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
    Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
    Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide.
    Guo M; Zhou J; Fan S; Li L; Chen H; Lin L; Zhao Q; Wang X; Liu W; Wu Z; Hai X
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):503-512. PubMed ID: 33678104
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
    Guo M; Zhao Q; Fan S; Wu Z; Lin L; Chen H; Gao Y; Hai X
    Br J Clin Pharmacol; 2021 Oct; 87(10):4020-4026. PubMed ID: 33638869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. As3MT and GST Polymorphisms Influencing Arsenic Metabolism in Human Exposure to Drinking Groundwater.
    González-Martínez F; Sánchez-Rodas D; Varela NM; Sandoval CA; Quiñones LA; Johnson-Restrepo B
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Šlejkovec Z; Podgornik H; Černelč P; Falnoga I
    Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between Arsenic (+3 Oxidation State) Methyltransferase Genetic Polymorphisms and Methylation Capacity of Inorganic Arsenic].
    Agusa T; Kunito T; Minh Tue N; Thi Mai Lan V; Binh Minh T; Thi Kim Trang P; Fujihara J; Takeshita H; Takahashi S; Hung Viet P; Tanabe S; Iwata H
    Nihon Eiseigaku Zasshi; 2015; 70(3):186-96. PubMed ID: 26411936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene-environment interaction and maternal arsenic methylation efficiency during pregnancy.
    Gao S; Mostofa MG; Quamruzzaman Q; Rahman M; Rahman M; Su L; Hsueh YM; Weisskopf M; Coull B; Christiani DC
    Environ Int; 2019 Apr; 125():43-50. PubMed ID: 30703610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.